New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Advanced Healthcare Materials · 2023-06 · 12 (14)
DOI: 10.1002/adhm.202201784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.11.2022. Verfasst von Zhengpeng Wan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Hauptthemen laut MEDLINE: Microfluidics, Spheroids, Cellular. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Previous studies have developed vascularized tumor spheroid models to demonstrate the impact of intravascular flow on tumor progression and treatment. However, these models have not been widely adopted so the vascularization of tumor spheroids in vitro is generally lower than vascularized tumor tissues in vivo. To improve the tumor vascularization level, a new strategy is introduced to form tumor spheroids by adding fibroblasts (FBs) sequentially to a pre‐formed tumor spheroid and demonstrate this method with tumor cell lines from kidney, lung, and ovary cancer. Tumor spheroids made with the new strategy have higher FB densities on the periphery of the tumor spheroid, which tend to enhance vascularization. The vessels close to the tumor spheroid made with this new strategy are more perfusable than the ones made with other methods. Finally, chimeric antigen receptor (CAR) T cells are perfused under continuous flow into vascularized tumor spheroids to demonstrate immunotherapy evaluation using vascularized tumor‐on‐a‐chip model. This new strategy for establishing tumor spheroids leads to increased vascularization in vitro, allowing for the examination of immune, endothelial, stromal, and tumor cell responses under static or flow conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, 510515, China.
ORCID-Profile: Zhengpeng Wan, Roger D Kamm
Förderung
- NCI NIH HHS
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023). New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay. Advanced Healthcare Materials, 12(14). https://doi.org/10.1002/adhm.202201784
Vancouver
Wan Z, Floryan MA, Coughlin MF, Zhang S, Zhong AX, Shelton SE, et al. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay. Advanced Healthcare Materials. 2023;12(14). doi:10.1002/adhm.202201784
BibTeX
@article{Wan2023,
author = {Wan, Zhengpeng and Floryan, Marie A and Coughlin, Mark F and Zhang, Shun and Zhong, Amy X and Shelton, Sarah E and Wang, Xun and Xu, Chenguang and Barbie, David A and Kamm, Roger D},
title = {New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {14},
doi = {10.1002/adhm.202201784}
}
EUVIMED